Orca Bio Appoints Nate Fernhoff As Chief Executive Officer
05/13/25, 7:54 AM
Location
menlo parkIndustry
therapeutics
biotechnology
health care
Position
chief executive officer
Orca Bio has announced the appointment of Nate Fernhoff, Ph.D., as Chief Executive Officer, succeeding Ivan Dimov, Ph.D. Jeroen Bekaert, Ph.D., has been appointed as President, further strengthening the company's leadership team.
Company Info
Location
menlo park, california, united states
Additional Info
Orca Bio is a late-stage biotechnology company dedicated to transforming the lives of patients through high-precision cell therapy. The company is focused on developing innovative T-cell immunotherapies for the treatment of blood cancers. Their lead investigational products, Orca-T and Orca-Q, are currently being evaluated in pivotal clinical trials. Orca Bio aims to deliver high-precision therapies to patients who could greatly benefit from improved treatment options.